Global Enzyme Linked Immunosorbent Assay Market Driven By Rising Adoption In Health Care Industry
![]() |
| Enzyme Linked Immunosorbent Assay Market |
Enzyme linked immunosorbent assay (ELISA) is an effective, sensitive and widely adopted method for detecting and measuring target proteins and peptides in biological samples. Some key applications of ELISA include cancer diagnosis and screening, HIV screening, sports drugs testing and other diagnostic tests. ELISA techniques have made diagnostics efficient, economical and less labor intensive. The global ELISA market offers kits, reagents and analyzer instruments to deliver reliable detection capabilities for various disease biomarkers. The rising incidence of chronic and infectious diseases has significantly increased diagnosis volumes, thus driving the ELISA market growth.
The global Enzyme Linked Immunosorbent
Assay Market is estimated to be valued at US$ 2118.92 Mn in 2023 and
is expected to exhibit a CAGR of 8.8% over the forecast period 2023 to 2030, as
highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the major trends in the enzyme linked immunosorbent assay market is the
increasing demand for multiplex ELISA technology. Multiplex ELISA allows
detection of multiple protein biomarkers in a single sample simultaneously.
Since many diseases involve changes in multiple protein biomarkers rather than
a single biomarker, multiplex ELISA provides more accurate disease detection
compared to conventional single-plex ELISA. Major companies in this market are
focusing on developing high-plex ELISA kits and analyzers to facilitate
multi-marker disease screening. This trend is expected to continue in coming
years with advancement in multiplexing technologies.
Porter's Analysis
Threat of new entrants: The threat of new entrants is moderate as the ELISA
market has high startup costs. However, specialized knowledge and technology
are barriers to entry.
Bargaining power of buyers: The bargaining power of buyers is high as buyers
have many choices of suppliers to choose from. Buyers can negotiate on price
and quality.
Bargaining power of suppliers: The bargaining power of suppliers is moderate.
There are many suppliers for inputs like reagents and equipment. Suppliers do
not have pricing power over molecule manufacturers.
Threat of new substitutes: The threat of substitutes is moderate as new
technologies like RT-PCR pose competition. However, ELISA is well established
and remains the gold standard for many applications.
Competitive rivalry: Competition is intense as many large players operate
globally. Players compete on technology, innovation, pricing and service.
Key Takeaways
The global Enzyme
Linked Immunosorbent Assay market Growth is expected to witness high
growth. The global Enzyme Linked Immunosorbent Assay Market is estimated to be
valued at US$ 2118.92 Mn in 2023 and is expected to exhibit a CAGR of 8.8% over the forecast period 2023 to 2030.
North America currently dominates the market and is
expected to continue its dominance over the forecast period. High prevalence of
chronic and infectious diseases and strong healthcare research funding are key
growth drivers in the region. Asia Pacific is expected to be the fastest-growing region in the ELISA market. Increasing healthcare expenditure, strict
regulations regarding food testing and rising cases of chronic diseases are
driving demand. China and India are emerging as lucrative markets.
Key players related content comprises: Key players operating in the Enzyme
Linked Immunosorbent Assay market are DSV, a.p. moller - maersk, United Parcel
Service of America, Inc., XPO Logistics Inc., DHL International GmbH,
Kuehne+Nagel Inc., Geodis, FedEx Corporation, C.H. Robinson Worldwide, Inc., db
schenker. These players are focusing on new product launches and acquisitions
to strengthen their market position.

Comments
Post a Comment